A randomized, controlled, open label, investigator initiated clinical study to evaluate the effect of Nixiyax along with standard of care treatment in comparison with standard of care alone on mental wellbeing in subjects with acne vulgaris.

Curatio Healthcare I Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1Known conditions that may interfere with the evaluation of acne vulgaris. Such conditions include but are not limited to the following: rosacea; seborrheic dermatitis; perioral dermatitis; corticosteroid-induced acne or folliculitis; carcinoid syndrome; squamous cell carcinoma; mastocytosis; acneiform eruptions caused by make-up or medication; bacterial folliculitis; facial psoriasis; and facial eczema.
•2Subjects allergic to herbal products or any component of the study product
•3Subjects who have been treated topical or oral corticosteroids within 14 days prior to baseline
•4History of uncontrolled disease or immune deficient disorder
•5Any feature in the test areas (face) that according to the investigator may influence the results, for example, but not limited to moles, tattoos, scars, irritated skin, scratches, cuts and excess hair
•6Known HIV or Hepatitis B positive or any other immuno-compromised state
•7Female subjects who are pregnant, nursing or planning to become pregnant during study participation
•8Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study
•9Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study

发起方

Curatio Healthcare I Pvt Ltd